Oxidative stress in hypobaric hypoxia and influence on vessel-tone modifying mediators

High Altitude Medicine and Biology

Volumn 14, Issue 3, 2013, Pages 273-279

  Pichler Hefti, Jacqueline ^a,b   Sonntag, Denise ^c   Hefti, Urs ^d   Risch, Lorenz ^e   Schoch, Otto D ^f   Turk, Alexander J ^g   Hess, Thomas ^h   Bloch, Konrad E ^g   Maggiorini, Marco ^g   Merz, Tobias M ^b   Weinberger, Klaus M ^c   Huber, Andreas R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BIOCRATES LIFE SCIENCES AG   (Austria)

^d Swiss Sport Clinic   (Switzerland)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Hypobaric hypoxia; Hypoxic pulmonary vasoconstriction; Nitric oxide; Oxidative stress

Indexed keywords

ARGININE; CITRULLINE; LIPID; METHIONINE; METHIONINE SULFOXIDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; SEROTONIN; TETRAHYDROBIOPTERIN; TRYPTOPHAN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; AGED; ALTITUDE; ARTICLE; BLOOD SAMPLING; ENZYME ACTIVITY; FEMALE; FUNCTIONAL DISEASE; HUMAN; HUMAN EXPERIMENT; HYPOBARISM; HYPOXEMIA; HYPOXIA; LIPID OXIDATION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; OXYGEN SATURATION; PEROXIDATION; PRIORITY JOURNAL; SULFOXIDATION; VASOCONSTRICTION;

ADULT; AGED; ALTITUDE; ALTITUDE SICKNESS; AMINO ACIDS; ANOXIA; ARGININE; BLOOD VESSELS; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; METHIONINE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; OXYGEN; PRESSURE; SEROTONIN;

EID: 84884791689     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2012.1110     Document Type: Article

References (27)

1. Araneda OF, Garcia C, Lagos N, et al. (2005). Lung oxidative stress as related to exercise and altitude. Lipid peroxidation evidence in exhaled breath condensate: a possible predictor of acute mountain sickness. Eur J Appl Physiol 95:383-390.
2. Bailey DM, Dehnert C, Luks AM, et al. (2010). High-altitude pulmonary hypertension is associated with a free radicalmediated reduction in pulmonary nitric oxide bioavailability. J Physiol 588:48374847.
3. Bailey DM, Evans KA, James PE, et al. (2009). Altered free radical metabolism in acute mountain sickness: Implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol 587:73-85.
4. Burhop KE, Selig WM, and Malik AB. (1988). Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 62:687-698.
5. Chawengsub Y, Gauthier KM, and Campbell WB. (2009). Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am J Physiol Heart Circ Physiol 297:H495-507.
6. Demarco VG, Whaley-Connell AT, Sowers JR, Habibi J, and Dellsperger KC. (2010). Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol 2:316-324.
7. Duplain H, Sartori C, Lepori M, et al. (2000). Exhaled nitric oxide in high-altitude pulmonary edema: Role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 162:221-224.
8. Forstermann U. (2010). Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459:923-939.
9. Gomase VS, Changbhale SS, Patil SA, and Kale KV. (2008). Metabolomics. Curr Drug Metab 9:89-98.
10. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, and Kell DB. (2004). Metabolomics by numbers: Acquiring and understanding global metabolite data. Trends Biotechnol 22:245-252.
11. Jerkic M, Kabir MG, Davies A, et al. (2011). Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. Cardiovasc Res 92:375-384.
12. Lane KL, Talati M, Austin E, et al. (2011). Oxidative injury is a common consequence of BMPR2 mutations. Pulm Circ 1:72-83.
13. Lawrie A, Spiekerkoetter E, Martinez EC, et al. (2005). Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 97:227-235.
14. Lee KS, Kim SR, Park SJ, et al. (2006). Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am J Respir Cell Mol Biol 35:190-197.
15. Lluch P, Mauricio MD, Vila JM, et al. (2006). Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp Biol Med (Maywood) 231:70-75.
16. Ma C, Li Y, Ma J, et al. (2011). Key role of 15-lipoxygenase/15- hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension 58:679-688.
17. MacAllister RJ, Parry H, Kimoto M, et al. (1996). Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119:1533-1540.
18. Maggiorini M, Melot C, Pierre S, et al. (2001). High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103:2078-2083.
19. Morecroft I, Dempsie Y, Bader M, et al. (2007).Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxiainduced pulmonary hypertension. Hypertension 49:232-236.
20. Niki E. (2008). Lipid peroxidation products as oxidative stress biomarkers. Biofactors 34:171-180.
21. Nishiyama M, Okamoto H, Watanabe T, et al. (1998). Endothelium is required for 12-hydroperoxyeicosatetraenoic acid-induced vasoconstriction. Eur J Pharmacol 341:57-63.
22. Sylvester JT, Shimoda LA, Aaronson PI, and Ward JP. (2012). Hypoxic pulmonary vasoconstriction. Physiol Rev 92:367-520.
23. Vallance P, Leone A, Calver A, Collier J, and Moncada S. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575.
24. Vogt W. (1995). Oxidation of methionyl residues in proteins: Tools, targets, and reversal. Free Radic Biol Med 18:93-105.
25. Wishart DS, Tzur D, Knox C, et al. (2007). HMDB: The Human Metabolome Database. Nucleic Acids Res 35:D521-526.
26. Yiu SS, Zhao X, Inscho EW, and Imig JD. (2003). 12- Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. J Lipid Res 44:2391-2399.
27. Yoshida Y, and Niki E. (2006). Bio-markers of lipid peroxidation in vivo: Hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 27:195-202.